User contributions for Lbordihn

29 November 2024

• 14:1914:19, 29 November 2024 diff hist +142 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary
• 13:5813:58, 29 November 2024 diff hist −14 Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study No edit summary current
• 13:5813:58, 29 November 2024 diff hist +58 Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study No edit summary
• 13:5713:57, 29 November 2024 diff hist −14 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary current
• 13:5713:57, 29 November 2024 diff hist +80 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
• 13:5613:56, 29 November 2024 diff hist −14 Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 No edit summary current
• 13:5613:56, 29 November 2024 diff hist +102 Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 No edit summary
• 13:5113:51, 29 November 2024 diff hist −14 Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial No edit summary current
• 13:5013:50, 29 November 2024 diff hist +157 Togni et al. (2015): Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial No edit summary
• 13:5013:50, 29 November 2024 diff hist −14 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary current
• 13:5013:50, 29 November 2024 diff hist +289 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
• 13:4713:47, 29 November 2024 diff hist −14 Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients No edit summary current
• 13:4713:47, 29 November 2024 diff hist +117 Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients No edit summary
• 13:4613:46, 29 November 2024 diff hist −14 Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy No edit summary current Tag: Manual revert
• 13:4613:46, 29 November 2024 diff hist +14 Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy No edit summary Tag: Manual revert
• 13:4513:45, 29 November 2024 diff hist −14 Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy No edit summary
• 13:4513:45, 29 November 2024 diff hist +88 Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy No edit summary
• 13:4413:44, 29 November 2024 diff hist −14 Sun et al. (2016): A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy No edit summary current
• 13:4413:44, 29 November 2024 diff hist +142 Sun et al. (2016): A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy No edit summary
• 13:4313:43, 29 November 2024 diff hist −14 Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia No edit summary current
• 13:4313:43, 29 November 2024 diff hist +355 Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia No edit summary
• 13:4213:42, 29 November 2024 diff hist −14 Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial No edit summary current
• 13:4213:42, 29 November 2024 diff hist +142 Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial No edit summary
• 13:4113:41, 29 November 2024 diff hist −14 Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients No edit summary
• 13:4013:40, 29 November 2024 diff hist +142 Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy No edit summary current
• 13:3813:38, 29 November 2024 diff hist −14 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary current
• 13:3813:38, 29 November 2024 diff hist +217 Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial No edit summary
• 13:3613:36, 29 November 2024 diff hist −14 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary current
• 13:3613:36, 29 November 2024 diff hist +181 Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study No edit summary
• 13:3513:35, 29 November 2024 diff hist −14 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary current
• 13:3513:35, 29 November 2024 diff hist +188 Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy No edit summary
• 13:3013:30, 29 November 2024 diff hist −14 Vinzenz et al. (1992): Die Therapie der radiogenen Mukositis mit Enzymen No edit summary current
• 13:2913:29, 29 November 2024 diff hist +160 Vinzenz et al. (1992): Die Therapie der radiogenen Mukositis mit Enzymen No edit summary
• 13:2913:29, 29 November 2024 diff hist −14 Tan et al. (2018): Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor No edit summary current
• 13:2813:28, 29 November 2024 diff hist −14 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary current
• 13:2813:28, 29 November 2024 diff hist +286 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
• 13:2713:27, 29 November 2024 diff hist −14 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary current
• 13:2713:27, 29 November 2024 diff hist +202 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
• 13:2613:26, 29 November 2024 diff hist −15 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary current
• 13:2613:26, 29 November 2024 diff hist +202 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
• 13:2513:25, 29 November 2024 diff hist −14 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary current
• 13:2513:25, 29 November 2024 diff hist +370 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
• 13:2313:23, 29 November 2024 diff hist −14 Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy No edit summary current
• 13:2313:23, 29 November 2024 diff hist +160 Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy No edit summary
• 13:2313:23, 29 November 2024 diff hist −14 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary current
• 13:2313:23, 29 November 2024 diff hist +244 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
• 13:2213:22, 29 November 2024 diff hist −14 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary current
• 13:2213:22, 29 November 2024 diff hist +202 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary
• 13:0413:04, 29 November 2024 diff hist −14 Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy No edit summary current
• 13:0413:04, 29 November 2024 diff hist +64 Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy No edit summary